Sizing clinical trials with variable endpoint event rates

Statistics in Medicine

Volumn 16, Issue 20, 1997, Pages 2267-2282

  Mové, Lemuel A ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; EXPECTATION; PROBABILITY; SAMPLE; STATISTICAL ANALYSIS; VARIANCE;

BAYES THEOREM; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; HUMANS; RANDOMIZED CONTROLLED TRIALS; SAMPLE SIZE;

EID: 0030702869     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19971030)16:20<2267::AID-SIM671>3.0.CO;2-1     Document Type: Article

References (22)

1. Meinert, C. L. Clinical Trials Design, Conduct and Analysis, Oxford University Press, 1986.
2. Lachin, J. M. 'Introduction to sample size determinations and power analyses for clinical trials', Controlled Clinical Trials, 2, 93-114 (1981).
3. Sahai, H. and Khuroid, A. 'Formulae and tables for determination of sample size and power in clinical trials for testing differences in proportions for the two sample design', Statistics in Medicine, 15, 1-21 (1996).
4. Snedecor, G. W. and Cochran, W. G. Statistical Methods, 4th ed, Iowa University Press, 1980.
5. The SHEP Cooperative Research Group. 'Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension', Journal of Clinical Epidemiology, Vol 41, (12), 1197-1208 (1988).
6. The SHEP Cooperative Research Group. 'Prevention of stroke by antihypertensive drug therapy in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program (SHEP)', Journal of the American Medical Association, 265, (24), 3255-3264 (1991).
7. Sacks, F. M., Pfeffer, M. A., Moyé, L. A., Brown, L. E., Hamm, P., Cole, T. G., Hawkins, C. M., Braunwald, E. 'The cholesterol and recurrent events trial (CARE Clinical Trial): rationale, design and baseline characteristics of secondary prevention trial of lowering serum cholesterol and myocardial infarction', American Journal of Cardiology, 68, (15), 1436-1446 (1991).
8. Moyé, L. A. for the SAVE Cooperative Group. 'Rationale and design of a trial to assess patient survival and ventricular enlargement after myocardial infarction', Journal of American Cardiology 68 710-790 (1991).
9. Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flkaker, G. T. C., Klein, M., Lamas, G. A., Packer, M., Rouleau, J., Rouleau, J. L., Rutherford, J., Wertheimer, J. K., Hawkins, C. M. 'Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction-results of the Survival and Ventricular Enlargement Trial', New England Journal of Medicine, 327, (10), 669-677 (1992).
10. Donner, A. 'Approach to sample size estimation in the design of clinical trials - a review', Statistics in Medicine, 3, 199-214 (1984).
11. Davy, S. J. and Graham, O. T. 'Sample size estimation for comparing two or more treatment groups in clinical trials', Statistics in Medicine, 10, 3-43 (1991).
12. Follmann, D. 'Multivariate tests for multiple endpoints in clinical trials', Statistics in Medicine, 14, 1163-1175 (1995).
13. George, S. L. and Desu, M. M. 'Planning the size and duration of a clinical trial studying the time to some critical event', Journal of Chronic Disease, 27, 15-24 (1974).
14. Hornberger, J. C., Brown, B. W. and Halpern, J. 'Designing a cost effective clinical trial', Statistics in Medicine, 14, 2249-2259 (1995).
15. Browne, R. H. 'On the use of a pilot study for sample size determinations', Statistics in Medicine, 14, 1933-1940 (1995).
16. Feng, Z. and Grizzle, J. E. 'Correlated binomial variates: properties of estimation of intraclass correlation and its effect on sample size calculation, Statistics in Medicine, 11, (12), 1607-1614 (1992).
17. Spiegahalter, D. J., Freedman, L. S. and Parmar, M. K. B. 'Applying Bayesian ideas in drug development and clinical trials', Statistics in Medicine, 12, 1501-1511 (1993).
18. Arjas, E. and Liu, L. 'Nonparametric Bayesian approach to hazard regression: a case study with a large number of missing covariate values', Statistics in Medicine, 15, 1757-1770 (1996).
19. Whitehead, J. and Brunier, H. 'Bayesian discussion procedure for dose determining experiments', Statistics in Medicine, 14, 885-893 (1995).
20. Thall, P. F., Simon, R. M. and Estey, E. H. 'Bayesian sequential monitoring designs for a single arm clinical trials with multiple outcomes', Statistics in Medicine, 14, 357-379 (1995).
21. Berry, D. A. 'Interim analysis in clinical trials: classical vs Bayesian approach', Statistics in Medicine, 4, 521-526 (1995).
22. Rosner, G. L. and Berry, D. A. 'A Bayesian group sequential design for a multiple arm randomized clinical trial', Statistics in Medicine, 14, 381-394 (1995).